{
    "2019-11-20": [
        [
            {
                "time": "2018-03-15",
                "original_text": "Charity to pay $4 million to resolve U.S. pharma kickback probe",
                "features": {
                    "keywords": [
                        "Charity",
                        "pharma",
                        "kickback",
                        "probe"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2019-05-20",
                "original_text": "Novartis Is Moving Higher on the Charts, Go Long or Add to Longs",
                "features": {
                    "keywords": [
                        "Novartis",
                        "Moving Higher",
                        "Go Long"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-11-12",
                "original_text": "Medicines Company Up on Rumors of Potential Buyout by Novartis",
                "features": {
                    "keywords": [
                        "Medicines Company",
                        "Rumors",
                        "Buyout",
                        "Novartis"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-06-05",
                "original_text": "Keytruda researcher launches cancer-focused Werewolf Therapeutics with $56M",
                "features": {
                    "keywords": [
                        "Keytruda",
                        "cancer-focused",
                        "Werewolf Therapeutics",
                        "launches"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "biotech"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}